Cancer-associated fibroblasts (CAFs) secrete collagen and fibronectin under SASP influence, while lysyl oxidase (LOX)-mediated ECM crosslinking increases tissue stiffness, activating integrin-FAK signaling to accelerate metastasis and confer therapy resistance (76). This evidence concerns the gene LOX and cancer.